Trial intelligence / Profile preview

Levothyroxine for pulmonary function in subclinical hypothyroidism

IRCT20180811040767N1Phase 3Completed

Sponsor
Zahedan University of Medical Sciences
Start
Dec 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of levothyroxine sodium in hypothyroidism, sponsored by Zahedan University of Medical Sciences. Primary endpoint: Change in pulmonary function tests. Started Dec 2018; status: completed.

02

Drugs

levothyroxine sodium
03

Conditions

hypothyroidism

Beyond the preview

Go deeper on IRCT20180811040767N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20180811040767N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call